Measures have been prepared to improve administrative and economic losses caused by drug returns in hospitals, clinics, and pharmacies following the revision of the monthly drug benefit list and upper limit table. The HIRA has decided to provide a revision of the drug benefit list in advance starting this month. Until now, drug price files have been provided since the revision of the notice after deliberation and resolution by the Health Insurance Policy Deliberation Committee of the MOHW. However, in the future, even before the issuance of the notice, after the Health Policy Review Committee is over, the drug price file will be provided in advance from the first day of the review. The final contents of the drug price fi